Drug lookup
Drug reference

ambenonium

Carbamate cholinesterase inhibitor · Anticholinesterase; Treatment for Myasthenia Gravis

Carbamate cholinesterase inhibitorAnticholinesterase; Treatment for Myasthenia Gravis
CDSCO approved
EXCRETION
not curated
INTERACTIONS
1 major
SEVERE in our sources
PREGNANCY
not curated
Top interactions
  • SiponimodSevereDatabaseDDInter

Mechanism

Ambenonium, a carbamoyl ester linked drug, inhibits acetylcholinesterase (AChE) by serving as an alternate substrate that is hydrolyzed much more slowly than acetylcholine. Its reaction with the active center serine progressively generates a carbamoylated enzyme, leading to prolonged inhibition of AChE-mediated acetylcholine hydrolysis.

Indications

myasthenia gravis

Drug interactions

Siponimod
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

11 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Ask House about ambenonium

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team